Stockreport

ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down [Yahoo! Finance]

Illumina, Inc.  (ILMN) 
Last illumina, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
PDF its new drug application (NDA) for oral sulopenem for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women. The FDA held the AMDAC meeting on [Read more]